Engineering NK-92 Cell by Upregulating CXCR2 and IL-2 Via CRISPR-Cas9 Improves Its Antitumor Effects as Cellular Immunotherapy for Human Colon Cancer

Journal of Interferon&Cytokine Research,Volume 41, Issue 12, Page 450-460, December 2021.

Source: Journal of Interferon - December 15, 2021 Category: Research Authors: Lanlan Gao Lili Yang Siyu Zhang Zuanmin Ge Meng Su Yanfei Shi Xuechun Wang Changxin Huang Source Type: research